Results 141 to 150 of about 3,186 (203)

A murine model of prurigo nodularis-like skin lesions induced by persistent scratching under type 2 inflammatory conditions. [PDF]

Front Immunol
Wu J, Li X, Huang S, Tang S, Zhang K, Yan J, Chen X, Dou X.   +7 more
europepmc   +1 more source

Successful Treatment of Upadacitinib in Prurigo Nodularis: A Case Report and Review of the Literature. [PDF]

Int Med Case Rep J
Li B, Yao W, Diao R, Yang B, Wang Y, Li T, Ge L, Wang H.   +7 more
europepmc   +1 more source

Dupilumab Reduces Pruritus in Clinically Distinct Dermatologic Diseases: Data from Clinical Trials on Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria [PDF]

Gil Yosipovitch, Brian Kim, John Koo, Zhen Chen, Simmi Wiggins, Joseph Zahn, Philip B. Sugerman, El‐Bdaoui Haddad, Sonya Cyr   +8 more
openalex   +1 more source

New-onset Autoimmune Diseases in Patients with Prurigo Nodularis: A Global-federated Retrospective Cohort Study. [PDF]

Acta Derm Venereol
Chang HC, Chang CC, Chu YJ, Hsu WT, Li YF, Jhang YS, Su YJ, Chen SJ, Zuberbier T, Gau SY.   +9 more
europepmc   +1 more source

Comparative safety profiles of dupilumab and nemolizumab in prurigo nodularis: an indirect META-analysis to inform clinical decision-making. [PDF]

Front Med (Lausanne)
Feng W, Wang D, Tan K, Zhang X.
europepmc   +1 more source

Atypical Presentation of Adult T-cell Leukaemia/Lymphoma due to HTLV-1: Prurigo Nodularis Lasting Twelve Years Followed by an Acute Micropapular Eruption

, 2010
A. Duval, Jacqueline Rivet, I. Moulonguet, Olivier Cassar, F. Agbalika, Donald F. H. Wallach, Antoine Gessain, A. Petit   +7 more
openalex   +2 more sources

Quantitative Evaluation of Nemolizumab Pharmacokinetics and Efficacy in Prurigo Nodularis: A Population Pharmacokinetics and Model-Based Meta-analysis Approach. [PDF]

Dermatol Ther (Heidelb)
Takechi T, Shimizu J, Kabashima K, Ieiri I.   +3 more
europepmc   +1 more source

Concurrent Nemolizumab-Induced Cutaneous Adverse Events and Asthma Exacerbation in a Patient With Prurigo Nodularis With Resolution of Both Conditions After Switching to Dupilumab. [PDF]

Cureus
Mima Y, Yamamoto M, Iozumi K.
europepmc   +1 more source

Recalcitrant Prurigo Nodularis Successfully Treated with Dupilumab. [PDF]

Indian Dermatol Online J
Anjaneyan G, Reddy S, Mathew L, Ponnamparambath V.   +3 more
europepmc   +1 more source